Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes

• Status: Unknown status
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To understand if acarbose, an alpha-glucosidase inhibitor usually for treating diabetes, will further lower post meal glucose and inflammatory state when taking together with moderate amount of alcohol during meal tolerance test in subjects with impaired glucose tolerance or mild diabetes.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taichung Veterans General Hospital
• Collaborator: Tri-Service General Hospital
• Treatments: Acarbose

Criteria

Inclusion Criteria:

• Subjects with mild diabetes without prior medications or impaired glucose tolerance

Exclusion Criteria:

• Pregnancy

• Recent major cardiac, renal and hepatic disease

• Intolerance to alcohol

• Allergy to acarbose treatment